These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37087364)

  • 1. Lipoprotein(a) levels in children with homozygous familial hypercholesterolaemia: A cross-sectional study.
    de Boer LM; Reijman MD; Hutten BA; Wiegman A
    J Clin Lipidol; 2023; 17(3):415-419. PubMed ID: 37087364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic systems approaches update molecular insights of clinical phenotypes and cardiovascular risk in patients with homozygous familial hypercholesterolemia.
    Du Z; Li F; Jiang L; Li L; Du Y; Yu H; Luo Y; Wang Y; Sun H; Hu C; Li J; Yang Y; Jiao X; Wang L; Qin Y
    BMC Med; 2023 Jul; 21(1):275. PubMed ID: 37501168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry.
    Cuchel M; Lee PC; Hudgins LC; Duell PB; Ahmad Z; Baum SJ; Linton MF; de Ferranti SD; Ballantyne CM; Larry JA; Hemphill LC; Kindt I; Gidding SS; Martin SS; Moriarty PM; Thompson PP; Underberg JA; Guyton JR; Andersen RL; Whellan DJ; Benuck I; Kane JP; Myers K; Howard W; Staszak D; Jamison A; Card MC; Bourbon M; Chora JR; Rader DJ; Knowles JW; Wilemon K; McGowan MP
    J Am Heart Assoc; 2023 May; 12(9):e029175. PubMed ID: 37119068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia.
    Pérez de Isla L; Watts GF; Alonso R; Díaz-Díaz JL; Muñiz-Grijalvo O; Zambón D; Fuentes F; de Andrés R; Padró T; López-Miranda J; Mata P
    Eur Heart J; 2021 Jun; 42(22):2201-2211. PubMed ID: 33437997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case Series Assessing the Effects of Lomitapide on Carotid Intima-Media Thickness in Adult Patients with Homozygous Familial Hypercholesterolaemia in a Real-World Setting.
    Blom DJ; Gaudet D; Hegele RA; Patel DS; Cegla J; Kolovou G; Marin LM
    Adv Ther; 2022 Apr; 39(4):1857-1870. PubMed ID: 35194765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Identification of Homozygous Familial Hypercholesterolemia by Long-Read Sequencing Among Patients With Clinically Diagnosed Heterozygous Familial Hypercholesterolemia.
    Chaudhry A; Trinder M; Vesely K; Cermakova L; Jackson L; Wang J; Hegele RA; Brunham LR
    Circ Genom Precis Med; 2023 Apr; 16(2):e003887. PubMed ID: 36960729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia.
    Mulder JWCM; Tromp TR; Al-Khnifsawi M; Blom DJ; Chlebus K; Cuchel M; D'Erasmo L; Gallo A; Hovingh GK; Kim NT; Long J; Raal FJ; Schonck WAM; Soran H; Truong TH; Boersma E; Roeters van Lennep JE;
    JAMA Cardiol; 2024 Apr; 9(4):313-322. PubMed ID: 38353972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia.
    Vuorio A; Watts GF; Kovanen PT
    Atherosclerosis; 2019 Feb; 281():25-30. PubMed ID: 30616181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society.
    Cuchel M; Bruckert E; Ginsberg HN; Raal FJ; Santos RD; Hegele RA; Kuivenhoven JA; Nordestgaard BG; Descamps OS; Steinhagen-Thiessen E; Tybjærg-Hansen A; Watts GF; Averna M; Boileau C; Borén J; Catapano AL; Defesche JC; Hovingh GK; Humphries SE; Kovanen PT; Masana L; Pajukanta P; Parhofer KG; Ray KK; Stalenhoef AF; Stroes E; Taskinen MR; Wiegman A; Wiklund O; Chapman MJ;
    Eur Heart J; 2014 Aug; 35(32):2146-57. PubMed ID: 25053660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
    Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
    J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-phenotype correlation in a large cohort of pediatric patients with heterozygous and homozygous familial hypercholesterolemia.
    Reijman MD; Defesche JC; Wiegman A
    Curr Opin Lipidol; 2023 Dec; 34(6):287-295. PubMed ID: 36752612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
    Vishwanath R; Hemphill LC
    J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Effectiveness of PCSK9 Inhibitors in Reducing LDL-C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries.
    Arca M; Celant S; Olimpieri PP; Colatrella A; Tomassini L; D'Erasmo L; Averna M; Zambon A; Catapano AL; Russo P
    J Am Heart Assoc; 2023 Nov; 12(21):e026550. PubMed ID: 37850449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities.
    Vuorio A; Watts GF; Schneider WJ; Tsimikas S; Kovanen PT
    J Intern Med; 2020 Jan; 287(1):2-18. PubMed ID: 31858669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypical, Clinical, and Molecular Aspects of Adults and Children With Homozygous Familial Hypercholesterolemia in Iberoamerica.
    Alves AC; Alonso R; Diaz-Diaz JL; Medeiros AM; Jannes CE; Merchan A; Vasques-Cardenas NA; Cuevas A; Chacra AP; Krieger JE; Arroyo R; Arrieta F; Schreier L; Corral P; Bañares VG; Araujo MB; Bustos P; Asenjo S; Stoll M; Dell'Oca N; Reyes M; Ressia A; Campo R; Magaña-Torres MT; Metha R; Aguilar-Salinas CA; Ceballos-Macias JJ; Morales ÁJR; Mata P; Bourbon M; Santos RD
    Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2508-2515. PubMed ID: 32757650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH.
    Anagnostis P; Rizos CV; Skoumas I; Rallidis L; Tziomalos K; Skalidis E; Kotsis V; Doumas M; Kolovou G; Sfikas G; Garoufi A; Lambadiari V; Dima I; Kiouri E; Agapakis D; Zacharis E; Antza C; Kolovou V; Koumaras C; Bantouvakis G; Liamis G; Liberopoulos EN
    Endocrine; 2022 May; 76(2):324-330. PubMed ID: 35262845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study.
    de Boer LM; Hutten BA; Zwinderman AH; Wiegman A
    Eur Heart J; 2023 Apr; 44(16):1421-1428. PubMed ID: 36382390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. It is Time to Screen for Homozygous Familial Hypercholesterolemia in the United States.
    Gidding SS; Ballantyne CM; Cuchel M; de Ferranti S; Hudgins L; Jamison A; McGowan MP; Peterson AL; Steiner RD; Uveges MK; Wang Y
    Glob Heart; 2024; 19(1):43. PubMed ID: 38708402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypercholesterolemia/autosomal dominant hypercholesterolemia: Molecular defects, the LDL-C continuum, and gradients of phenotypic severity.
    Foody JM; Vishwanath R
    J Clin Lipidol; 2016; 10(4):970-986. PubMed ID: 27578130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.